Skip to main content

10 results for"merrill goozner"

Search Again  |  Advanced Search Options
  • Type OR between all the words you want: LHC OR collider
  • Put exact search phrases in quotes: "Mars Rover"
  • Filter search results use the options below

Return of a Killer: Tuberculosis in Russia

Veteran journalist Merrill Goozner, director of the Integrity in Science project at the Center for Science in the Public Interest, discusses his series of articles for SciAm.com on the rise of tuberculosis in Russia. Plus, we'll test your knowledge of some recent science in the news. Web sites mentioned in this episode include www.gooznews.com; www.snipurl.com/goozner

August 27, 2008 — Steve Mirsky
What is Artemisinin?

What is Artemisinin?

Coartem, a malaria drug whose potency is derived from a Chinese herb, may soon be approved for sale in the United States.

December 23, 2008 — Jordan Lite

Evidence-based medicine in Russia: the challenge and the hope

[ Editor's note: Merrill Goozner has spent the last two weeks reporting on the state of Russian health care. See his previous posts from the field: "It's all about the oil: Russia's resurgence rests on slippery foundation" and "Russia boosts healthcare in Siberia" ]MOSCOW – On my last morning in Russia, I dined with Vasiliy Vlassov, professor of research methodology at the Moscow Medical Academy and head of a small but feisty group of Russian physicians called the Society of Specialists in Evidence-Based Medicine.

June 16, 2008 — Merrill Goozner

SciAm and CNN keep an eye on a Planet in Peril

Here at Scientific American , the fate of Earth is an important part of our coverage, from our new publication, Earth 3.0, to a grand plan for solar energy, to daily reporting on climate change.

December 9, 2008 — Ivan Oransky
Prisons in Post-Soviet Russia Incubate 
a Plague

Prisons in Post-Soviet Russia Incubate a Plague

The collapse of the Soviet health care system in the 1990s coupled with prisons releasing improperly treated inmates and endemic poverty escalated incidences of multidrug-resistant tuberculosis to epidemic proportions

August 25, 2008 — Merrill Goozner

In Pursuit of Better Weapons to Combat TB

Tuberculosis remains a stubborn foe despite the efforts of the public and private sector's efforts to deploy new antibiotics and diagnostic tools against a disease that thrives on poverty and ignorance

August 25, 2008 — Merrill Goozner

A Siberian Community Mobilizes to Fight TB

A Russian province bucks the national government, bringing tuberculosis treatment to the treated--and following through until they are cured. The results so far have been encouraging

August 25, 2008 — Merrill Goozner

Back to School

Get 50% off digital subscriptions of Scientific American and Scientific American MIND!